Unique Aspects of Breast Cancer in African American Women: TRIPLE NEGATIVE BREAST CANCER

Size: px
Start display at page:

Download "Unique Aspects of Breast Cancer in African American Women: TRIPLE NEGATIVE BREAST CANCER"

Transcription

1

2 Angel A. Rodriguez, M.D. Assistant Professor Weill Cornell Medical College Methodist Cancer Center January 26, 2013 Unique Aspects of Breast Cancer in African American Women: TRIPLE NEGATIVE BREAST CANCER

3 Awareness Early Detection Advocacy Diagnosis Survivorship Treatment

4 Breast Cancer Facts Breast cancer is the most common cancer among American women. 1 in 8 women will be diagnosed with breast cancer in her lifetime About 26,840 new cases of breast cancer among African American women 4

5 White women are slightly more likely to develop breast cancer than African-American women

6 Breast Cancer Survival Facts About 39,520 women will die from breast cancer Death rates from breast cancer have been declining since

7 Death rates from breast cancer have been declining since 1990 About 6,040 African american women die each year because of breast cancer

8 Survival Facts The 5-year survival rate for breast cancer diagnosed in : All 89.1 % African American 77.0 % White women 90.4 % Stage at Diagnosis 5-YR OS Localized 60 % 98.6 % Regional 33 % 83.8 % Distant 5 % 23.3 % 8

9 We have a problem We currently have some solutions: Identify women at risk Prevention Early detection Treatment 9

10 Hereditary Breast Cancer Sporadic Family Clusters Clearly Hereditary

11 ** Men can develop breast cancer too. ** Started/end menses ** Children ** Breast Feeding ** Diet ** Exercise ** Alcohol ** Risk of breast cancer increases with age ** Females have higher risk of breast cancer ** Family history matters ** Race matters ** Use of Hormones ** Environment Picture: Courtesy Web

12 Most cases of breast cancer are not hereditary Red Flags Triple Negative Breast Cancer Breast cancer before age 50 Ovarian cancer at any age Male breast cancer at any age Multiple primary cancers Ashkenazi Jewish ancestry Relatives of a BRCA mutation carrier AJHG 1998;62: JCO 2002;20:

13 BRCA: Lifetime Cancer Risks Type of Cancer General Population BRCA Female Breast Cancer 12% (mostly ER+) 80% (mostly TNBC) 2 nd Breast Cancer 6% 50% Ovarian Cancer 1.8% 40%

14 SCREENING Mammogram between age 35 and 40 Mammogram every year beginning age 40 Annual breast exam by a physician Talk to your doctor about ultrasound, MRI, and the newer technologies Body awareness, self breast exam

15 Staging 1. Early stage patients are highly curable Stage 0 (in situ) 99.9 % cure Stage 1 - >90% cure 2. Late stage disease is curable, but chances are lower Stage % cure Stage 4 Treatable

16

17

18 Breast Cancer is Not One Disease Breast Cancer ER- ER % ER+ HER % TNBC 15% BRCA1 <2%

19 TNBC Epidemiology Etiology Biology Prognosis Treatment options Who Why How What Current Future

20 Consistent Risk Modifiers for TNBC Age <50 African-American Family History Premenopausal overweight Breastfeeding!! 20

21

22 Triple Negative Breast Cancer TNBC HER2+ ER+ AA < 50 y/o AA > 50 y/o White < 50 y/o White > 50 y/o 39% 14% 16% 16% 9% 7% 6% 6% 36% 59% 51% 58% Carey LA et al, JAMA 2006 These findings have been observed in North Carolina, south Carolina, Atlanta, California and Pennsylvania

23 Current Treatments for TNBC Stage 1-3: Curable, but more difficult to treat than other breast cancer Surgery Chemotherapy 4 to 6 months Anthracycline: Adriamycin or Epirubicin Taxane: weekly or every 3 weeks Possibly radiation We need more effective and safer treatments

24 Current Treatments for Stage 4 TNBC Treatable with chemotherapy only, can shrink tumors The response of these treatments, although initially effective, are usually not long lasting. We need more effective and safer treatments. We need to find the switch!

25 After a Cancer Diagnosis You should be well informed You may have several treatment choices Learn about your options A. Standard of Care B. Clinical Trials, especially if high risk Make an informed decision about your treatment that you are comfortable with

26 Cancer Clinical Trial Done to find new ways to treat cancer We want more effective treatments We want safer treatments A new drug A new combination of drugs All cancer treatments you take now have been studied in past clinical trials

27

28 Example of TNBC Clinical Trial ARM 1 ARM 2 What your doctor recommended Same treatment as ARM 1 plus Herceptin 28

29 Clinical Trials Tuskegee Experiment An unethical and racist clinical study that tarnished the reputation of clinical research Black patients were deprived of curative treatment Led to the establishment of the Office for Human Research Protections

30 Institutional Review Boards Federal Law requires IRB for the protection of human subjects in studies involving human subjects Not just victims.heroes Charlie Pollard Herman Shaw Patients can now participate in clinical trials with secure feelings.

31 Awareness Early Detection Advocacy Diagnosis Survivorship Treatment

32 Tissue Understanding Of Cancer Resistance New Target New Treatments Clinical Trials

33 Cure Awareness Early Detection Tissue Understanding Of Cancer Advocacy Diagnosis Resistance Research Institutions New Target Survivorship Treatment New Treatments Clinical Trials

34 Goals Of Clinical Research Discover more effective therapies Decrease side effects Understand why cancer returns Understand why treatments stop working Access to newer therapies

35 Conclusion Get Mammograms Annually Take care of yourself Discuss your risk with your doctor Treatments for breast cancer are available Consider clinical trials, it s the only way we can find more cures Participate and educate 35

36 Thank you!! 36

Breast Cancer. American Cancer Society

Breast Cancer. American Cancer Society Breast Cancer American Cancer Society Reviewed February 2017 What we ll be talking about How common is breast cancer? What is breast cancer? What causes it? What are the risk factors? Can breast cancer

More information

Breast Cancer. Excess Estrogen Exposure. Alcohol use + Pytoestrogens? Abortion. Infertility treatment?

Breast Cancer. Excess Estrogen Exposure. Alcohol use + Pytoestrogens? Abortion. Infertility treatment? Breast Cancer Breast Cancer Excess Estrogen Exposure Nulliparity or late pregnancy + Early menarche + Late menopause + Cystic ovarian disease + External estrogens exposure + Breast Cancer Excess Estrogen

More information

WELCOME. Taking Care of Your Health. April 30, 8 am to noon

WELCOME. Taking Care of Your Health. April 30, 8 am to noon WELCOME Taking Care of Your Health April 30, 8 am to noon Cancer: Know Your Risk Emily Kuchinsky, MS, CGC, Certified Genetic Counselor Sporadic Cancer Lifetime Probability- Women Family Cluster Risk factors

More information

Triple Negative Breast Cancer: Part 2 A Medical Update

Triple Negative Breast Cancer: Part 2 A Medical Update Triple Negative Breast Cancer: Part 2 A Medical Update April 29, 2015 Tiffany A. Traina, MD Breast Medicine Service Memorial Sloan Kettering Cancer Center Weill Cornell Medical College Overview What is

More information

HBOC Syndrome A review of BRCA 1/2 testing, Cancer Risk Assessment, Counseling and Beyond.

HBOC Syndrome A review of BRCA 1/2 testing, Cancer Risk Assessment, Counseling and Beyond. HBOC Syndrome A review of BRCA 1/2 testing, Cancer Risk Assessment, Counseling and Beyond. Conni Murphy, ARNP Cancer Risk Assessment and Genetics Program Jupiter Medical Center Learning Objectives Identify

More information

HEALTH CARE DISPARITIES. Bhuvana Ramaswamy MD MRCP The Ohio State University Comprehensive Cancer Center

HEALTH CARE DISPARITIES. Bhuvana Ramaswamy MD MRCP The Ohio State University Comprehensive Cancer Center HEALTH CARE DISPARITIES Bhuvana Ramaswamy MD MRCP The Ohio State University Comprehensive Cancer Center Goals Understand the epidemiology of breast cancer Understand the broad management of breast cancer

More information

So, Who are the appropriate individuals that should consider genetic counseling and genetic testing?

So, Who are the appropriate individuals that should consider genetic counseling and genetic testing? Hello, I m Banu Arun, Professor of Breast Medical Oncology and Co-Director of Clinical Cancer Genetics at the University of Texas MD Anderson Cancer Center. Today I will be discussing with you Hereditary

More information

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious Understanding Your Genetic Test Result Positive for a Deleterious Mutation or Suspected Deleterious This workbook is designed to help you understand the results of your genetic test and is best reviewed

More information

Breast Cancer Screening and High Risk

Breast Cancer Screening and High Risk Breast Cancer Screening and High Risk Mary Freyvogel, DO Breast Surgeon Clinical Assistant Professor of Surgery University Hospitals Case Medical Center St. John Medical Center / Elyria Medical Center

More information

Assessment and Management of Genetic Predisposition to Breast Cancer. Dr Munaza Ahmed Consultant Clinical Geneticist 2/7/18

Assessment and Management of Genetic Predisposition to Breast Cancer. Dr Munaza Ahmed Consultant Clinical Geneticist 2/7/18 Assessment and Management of Genetic Predisposition to Breast Cancer Dr Munaza Ahmed Consultant Clinical Geneticist 2/7/18 Overview The role of the Cancer Genetics team NICE guidelines for Familial Breast

More information

Breast Cancer: Selected Topics for the Primary Care Clinician

Breast Cancer: Selected Topics for the Primary Care Clinician Breast Cancer: Selected Topics for the Primary Care Clinician Leah Karliner, MD MAS October 2009 Primary Care Medicine: Principles and Practice OUTLINE Incidence and Mortality Risk Factors and Risk Reduction/Prevention

More information

BRCA1 and BRCA2. patient guide. genetic testing for hereditary breast and ovarian cancer (hboc)

BRCA1 and BRCA2. patient guide. genetic testing for hereditary breast and ovarian cancer (hboc) patient guide BRCA1 and BRCA2 genetic testing for hereditary breast and ovarian cancer (hboc) Because knowing your risk can mean early detection and prevention Know the Basics People with HBOC may have

More information

Screening for Breast Cancer

Screening for Breast Cancer Understanding Task Force Recommendations Screening for Breast Cancer U.S. Preventive Services Task Force (Task Force) has issued a final recommendation statement on Screening for Breast Cancer. se final

More information

Understanding and Optimizing Treatment of Triple Negative Breast Cancer

Understanding and Optimizing Treatment of Triple Negative Breast Cancer Understanding and Optimizing Treatment of Triple Negative Breast Cancer Edith Peterson Mitchell, MD, FACP Clinical Professor of Medicine and Medical Oncology Program Leader, Gastrointestinal Oncology Department

More information

Shared Decision Making in Breast and Prostate Cancer Screening. An Update and a Patient-Centered Approach. Sharon K. Hull, MD, MPH July, 2017

Shared Decision Making in Breast and Prostate Cancer Screening. An Update and a Patient-Centered Approach. Sharon K. Hull, MD, MPH July, 2017 Shared Decision Making in Breast and Prostate Cancer Screening An Update and a Patient-Centered Approach Sharon K. Hull, MD, MPH July, 2017 Overview Epidemiology of Breast and Prostate Cancer Controversies

More information

Stage 3c breast cancer survival rate

Stage 3c breast cancer survival rate Stage 3c breast cancer survival rate There are five main subtypes of ovarian carcinoma, of which high-grade serous carcinoma is the most common. [3]. Testicular cancer is generally found in young men.

More information

Sporadic Cancer - Cancer which occurs by chance. People with sporadic cancer typically do not have relatives with the same type of cancer.

Sporadic Cancer - Cancer which occurs by chance. People with sporadic cancer typically do not have relatives with the same type of cancer. to risk assessment Hereditary Cancer Testing: Is it Right for You? This workbook is designed to help you decide if hereditary cancer testing is right for you and should be reviewed with a trained healthcare

More information

2017 Breast Cancer Update

2017 Breast Cancer Update 2017 Breast Cancer Update Alberto J Montero, M.D., MBA Quality Improvement Officer, Taussig Cancer Institute, Lerner College of Medicine Cleveland Clinic N/A Disclosure Overview Epidemiology (US/Global)

More information

Breast Cancer Basics. Clinical Oncology for Public Health Professionals. Ben Ho Park, MD, PhD

Breast Cancer Basics. Clinical Oncology for Public Health Professionals. Ben Ho Park, MD, PhD This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

So, now, that we have reviewed some basics of cancer genetics I will provide an overview of some common syndromes.

So, now, that we have reviewed some basics of cancer genetics I will provide an overview of some common syndromes. Hello. My name is Maureen Mork and I m a Certified Genetic Counselor in the Clinical Cancer Genetics Program at The University of Texas MD Anderson Cancer Center. I ll be lecturing today on the Cancer

More information

Factors Associated with Early Versus Late Development of Breast and Ovarian Cancer in BRCA1 and BRCA2 Positive Women

Factors Associated with Early Versus Late Development of Breast and Ovarian Cancer in BRCA1 and BRCA2 Positive Women Texas Medical Center Library DigitalCommons@The Texas Medical Center UT GSBS Dissertations and Theses (Open Access) Graduate School of Biomedical Sciences 5-2010 Factors Associated with Early Versus Late

More information

Case 1. BREAST CANCER From Diagnosis to Treatment: The Role of Primary Care

Case 1. BREAST CANCER From Diagnosis to Treatment: The Role of Primary Care BREAST CANCER From Diagnosis to Treatment: The Role of Primary Care Leah Karliner, MD MAS University of California San Francisco Primary Care Medicine Update 2009 April 2009 Case 1 AR, a 60 year old African

More information

What You Need to Know About. Breast Cancer. At Every Age. Partners for your health.

What You Need to Know About. Breast Cancer. At Every Age. Partners for your health. What You Need to Know About Breast Cancer At Every Age Partners for your health. Like many diseases, the risk of breast cancer increases as you age. About one out of eight invasive breast cancers develop

More information

Breast Imaging! Ravi Adhikary, MD!

Breast Imaging! Ravi Adhikary, MD! Breast Imaging! Ravi Adhikary, MD! ACS Estimated Cancers Statistics 2014! Breast! New Cases in Women! 232,670 (+67,570 in situ)! Deaths in Women! 40,000! Colon! 48,380! 24,040! Cervical! 12,360! 4,020!

More information

Screening for Genes for Hereditary Breast and Ovarian Cancer in Jewish Women

Screening for Genes for Hereditary Breast and Ovarian Cancer in Jewish Women Screening for Genes for Hereditary Breast and Ovarian Cancer in Jewish Women Background About 5% of women in Canada with breast cancer and about 12% of women with ovarian cancer, are born with an inherited

More information

Does Cancer Run in Your Family?

Does Cancer Run in Your Family? Does Cancer Run in Your Family? A Patient s Guide to Hereditary Breast and Ovarian Cancer Syndrome What is Hereditary Cancer? Most cancers occur in people who do not have a strong family history of that

More information

patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015

patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015 patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015 BRCA1 and BRCA2 Mutations Cancer is a complex disease thought to be caused by several different factors. A few types of cancer

More information

Cancer Survivorship Symposium Cancer and Heredity January 16, Jeanne P. Homer, MS Licensed Certified Genetic Counselor

Cancer Survivorship Symposium Cancer and Heredity January 16, Jeanne P. Homer, MS Licensed Certified Genetic Counselor Cancer Survivorship Symposium Cancer and Heredity January 16, 2017 Jeanne P. Homer, MS Licensed Certified Genetic Counselor Outline Cancer and Heredity Hereditary Cancer Risk Assessment & Genetic testing

More information

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious Understanding Your Genetic Test Result Positive for a Deleterious Mutation or Suspected Deleterious This workbook is designed to help you understand the results of your genetic test and is best reviewed

More information

Breast Cancer. Common kinds of breast cancer are

Breast Cancer. Common kinds of breast cancer are Breast Cancer A breast is made up of three main parts: glands, ducts, and connective tissue. The glands produce milk. The ducts are passages that carry milk to the nipple. The connective tissue (which

More information

Breast Cancer Awareness Presentation. MG-51647A Eli Lilly and Company. All Rights Reserved.

Breast Cancer Awareness Presentation. MG-51647A Eli Lilly and Company. All Rights Reserved. Breast Cancer Awareness Presentation MG-51647A 0408 2008 Eli Lilly and Company. All Rights Reserved. 1 Laurie Brown RN, MSN, MPA-HA, CCRN Professor of Nursing www.rnlaurie.com Presentation Objectives Understand

More information

patient guide BreastNext genetic testing for hereditary breast cancer Because knowing your risk can mean early detection and prevention

patient guide BreastNext genetic testing for hereditary breast cancer Because knowing your risk can mean early detection and prevention patient guide BreastNext genetic testing for hereditary breast cancer Because knowing your risk can mean early detection and prevention Know the Basics Breast cancer is the most common cancer in women

More information

National Community Health Worker Training Center (CCHD) Texas A & M School of Public Health

National Community Health Worker Training Center (CCHD) Texas A & M School of Public Health Breast Cancer Prevention & Detection National Community Health Worker Training Center (CCHD) Texas A & M School of Public Health Pre-test Disclaimer This study was funded by the Institute for Research

More information

SFMC Breast Cancer Site Study: 2011

SFMC Breast Cancer Site Study: 2011 SFMC Breast Cancer Site Study: 2011 Introduction Breast cancer is the most frequently diagnosed cancer among American women, except for skin cancers. It is the second leading cause of cancer death in women,

More information

BRCA1 & BRCA2 GeneHealth UK

BRCA1 & BRCA2 GeneHealth UK BRCA1 & BRCA2 GeneHealth UK BRCA1 & BRCA2 What is hereditary breast cancer? Cancer is unfortunately very common, with 1 in 2 people developing cancer at some point in their lifetime. Breast cancer occurs

More information

Assessing Your Patient s Breast Cancer Risk: Is Genetic Testing Necessary?

Assessing Your Patient s Breast Cancer Risk: Is Genetic Testing Necessary? May 16, 2016 Assessing Your Patient s Breast Cancer Risk: Is Genetic Testing Necessary? Presenter: Emily Kuchinsky, MS, CGC 1 Experiences with Genetic Testing Adverse Events in Cancer Genetic Testing:

More information

Breast Cancer in Women

Breast Cancer in Women The Crawford Clinic 1900 Leighton Avenue Suite 101 Anniston, Alabama 36207 Phone: 256-240-7272 Fax: 256-240-7242 Breast Cancer in Women What is breast cancer? When abnormal cells grow uncontrollably, they

More information

Wellness Along the Cancer Journey: Cancer Types Revised October 2015 Chapter 2: Breast Cancer

Wellness Along the Cancer Journey: Cancer Types Revised October 2015 Chapter 2: Breast Cancer Wellness Along the Cancer Journey: Cancer Types Revised October 2015 Chapter 2: Breast Cancer Cancer Types Rev. 10.20.15 Page 19 Breast Cancer Group Discussion True False Not Sure 1. Breast cancer is not

More information

Does Cancer Run in Your Family?

Does Cancer Run in Your Family? Does Cancer Run in Your Family? Nancie Petrucelli, MS, CGC Clinical Assistant Professor Certified Genetic Counselor/Coordinator Cancer Genetic Counseling Service Karmanos Cancer Institute Wayne State University

More information

TAKING CHARGE: SHARSHERET CANCER SCREENING UPDATES EVERY WOMAN NEEDS TO KNOW. Wednesday, July 8, 2015

TAKING CHARGE: SHARSHERET CANCER SCREENING UPDATES EVERY WOMAN NEEDS TO KNOW. Wednesday, July 8, 2015 Sharsheret 2015 SHARSHERET TAKING CHARGE: CANCER SCREENING UPDATES EVERY WOMAN NEEDS TO KNOW Wednesday, July 8, 2015 To listen to the presentation by phone, Dial: 866-952-1906 Code: SHARSHERET Sharsheret

More information

Current Strategies in the Detection of Breast Cancer. Karla Kerlikowske, M.D. Professor of Medicine & Epidemiology and Biostatistics, UCSF

Current Strategies in the Detection of Breast Cancer. Karla Kerlikowske, M.D. Professor of Medicine & Epidemiology and Biostatistics, UCSF Current Strategies in the Detection of Breast Cancer Karla Kerlikowske, M.D. Professor of Medicine & Epidemiology and Biostatistics, UCSF Outline ν Screening Film Mammography ν Film ν Digital ν Screening

More information

Clinico- Pathological Features And Out Come Of Triple Negative Breast Cancer

Clinico- Pathological Features And Out Come Of Triple Negative Breast Cancer Clinico- Pathological Features And Out Come Of Triple Negative Breast Cancer Dr. HassanAli Al-Khirsani, MBChB, CABM, F.I.C.M.S AL-Sadder teaching hospital, oncology unit Dr. Nasser Ghaly Yousif, MBChB,G.P.

More information

4/13/2010. Silverman, Buchanan Breast, 2003

4/13/2010. Silverman, Buchanan Breast, 2003 Tailoring Breast Cancer Treatment: Has Personalized Medicine Arrived? Judith Luce, M.D. San Francisco General Hospital Avon Comprehensive Breast Care Center Outline First, treatment of DCIS Sorting risk

More information

Update on BRCA testing thresholds NICE guidance changes

Update on BRCA testing thresholds NICE guidance changes Update on BRCA testing thresholds NICE guidance changes D Gareth R Evans Christie and St Mary s Hospital Manchester UK London July 2014 Guideline Development Group Familial Breast Cancer Any woman with

More information

Breast Cancer Update Michael B. Peyser MS MD FACS Fellow Society of Surgical Oncology Windsong Breast Care

Breast Cancer Update Michael B. Peyser MS MD FACS Fellow Society of Surgical Oncology Windsong Breast Care Breast Cancer Update 2017 Michael B. Peyser MS MD FACS Fellow Society of Surgical Oncology Windsong Breast Care Used with permission by Anna Chen MD, Windsong Radiology Group Statistics as of 2013 230,815

More information

GeneticsNow TM. A Guide to Testing Hereditary Conditions in Women & Men. Patient & Physician Information

GeneticsNow TM. A Guide to Testing Hereditary Conditions in Women & Men. Patient & Physician Information GeneticsNow TM A Guide to Testing Hereditary Conditions in Women & Men Patient & Physician Information How can BRCA status affect your health? Everyone has BRCA1 and BRCA2 genes. However, sometimes the

More information

BREAST CANCER. Dawn Hershman, MD MS. Medicine and Epidemiology Co-Director, Breast Program HICCC Columbia University Medical Center.

BREAST CANCER. Dawn Hershman, MD MS. Medicine and Epidemiology Co-Director, Breast Program HICCC Columbia University Medical Center. BREAST CANCER Dawn Hershman, MD MS Florence Irving Assistant Professor of Medicine and Epidemiology Co-Director, Breast Program HICCC Columbia University Medical Center Background Breast cancer is the

More information

Cancer Genomics 101. BCCCP 2015 Annual Meeting

Cancer Genomics 101. BCCCP 2015 Annual Meeting Cancer Genomics 101 BCCCP 2015 Annual Meeting Objectives Identify red flags in a person s personal and family medical history that indicate a potential inherited susceptibility to cancer Develop a systematic

More information

Hereditary Breast and Ovarian Cancer Rebecca Sutphen, MD, FACMG

Hereditary Breast and Ovarian Cancer Rebecca Sutphen, MD, FACMG Hereditary Breast and Ovarian Cancer 2015 Rebecca Sutphen, MD, FACMG Among a consecutive series of 11,159 women requesting BRCA testing over one year, 3874 responded to a mailed survey. Most respondents

More information

Breast Cancer A Discussion for the JWA. Amy Mines Tadelis

Breast Cancer A Discussion for the JWA. Amy Mines Tadelis Breast Cancer A Discussion for the JWA Amy Mines Tadelis WHAT IS CANCER PREVENTION? Cancer prevention is action taken to lower the chance of getting cancer; the number of new cases of cancer in a group

More information

Tissue Breast Density

Tissue Breast Density Tissue Breast Density Reporting breast density within the letter to the patient is now mandated by VA law. Therefore, this website has been established by Peninsula Radiological Associates (PRA), the radiologists

More information

Visual Guide To Breast Cancer

Visual Guide To Breast Cancer Breast Cancer Today Breast cancer today is not what it was 20 years ago. Survival rates are climbing, thanks to greater awareness, more early detection, and advances in treatment. For roughly 200,000 Americans

More information

OBJECTIVES 8/25/2017. An attempt to organize the chaos

OBJECTIVES 8/25/2017. An attempt to organize the chaos High Risk for Breast Cancer and Genetics: Who? What? Where? When? An attempt to organize the chaos Presented at Winds of Change Conference November 3, 2017 by Carol Hager, MSN, CRNP and Allison Haener,

More information

Breast cancer staging update. Ekaterini Tsiapali, MD, FACS MedStar Regional Breast Program Site Director

Breast cancer staging update. Ekaterini Tsiapali, MD, FACS MedStar Regional Breast Program Site Director Breast cancer staging update Ekaterini Tsiapali, MD, FACS MedStar Regional Breast Program Site Director 1 1 Review of the AJCC 8 th edition breast cancer staging Review of genomic assays as stage modifiers

More information

Risk Assessment, Genetics, and Prevention

Risk Assessment, Genetics, and Prevention Risk Assessment, Genetics, and Prevention Katherine D. Crew, MD MS Director, Clinical Breast Cancer Prevention Program Columbia University Medical Center 1 Outline Breast cancer risk factors Hereditary

More information

Primary Care Approach to Genetic Cancer Syndromes

Primary Care Approach to Genetic Cancer Syndromes Primary Care Approach to Genetic Cancer Syndromes Jason M. Goldman, MD, FACP FAU School of Medicine Syndromes Hereditary Breast and Ovarian Cancer (HBOC) Hereditary Nonpolyposis Colorectal Cancer (HNPCC)

More information

What is Cancer? Petra Ketterl, MD Medical Oncology and Functional Medicine

What is Cancer? Petra Ketterl, MD Medical Oncology and Functional Medicine What is Cancer? Petra Ketterl, MD Medical Oncology and Functional Medicine What is Cancer? Layman s terms: cancer starts when cells grow out of control (in any place in the body) and crowd out normal cells

More information

Genetic Screening Visit

Genetic Screening Visit Before your visit In a typical hereditary breast ovarian cancer genetic counsling visit be prepared to answer the following set of questions, please check were applicable. About your self (same questions

More information

POSITIVE DELETERIOUS MUTATION

POSITIVE DELETERIOUS MUTATION Understanding Your Genetic Test Result Positive for a Deleterious or Suspected Deleterious POSITIVE DELETERIOUS MUTATION This workbook is designed to help you understand the results of your genetic test

More information

e-session 381 BCY3 - Highlights of the 3rd ESO-ESMO Breast Cancer in Young Women International Conference

e-session 381 BCY3 - Highlights of the 3rd ESO-ESMO Breast Cancer in Young Women International Conference Expert: Dr Olivia Pagani, Oncology Institute of Southern Switzerland, Lugano, Switzerland Discussant: Dr Fedro Alessandro Peccatori, European Institute of Oncology, Milan, Italy e-session 381 BCY3 - Highlights

More information

Genetic Testing: who, what, why?

Genetic Testing: who, what, why? Genetic Testing: who, what, why? Gina Westhoff MD LMG Gynecologic Oncology March 16, 2019 Disclosures Speaker for Merck (unrelated to today s topic) Objectives Determine who should undergo genetic risk

More information

6/8/17. Genetics 101. Professor, College of Medicine. President & Chief Medical Officer. Hereditary Breast and Ovarian Cancer 2017

6/8/17. Genetics 101. Professor, College of Medicine. President & Chief Medical Officer. Hereditary Breast and Ovarian Cancer 2017 Genetics 101 Hereditary Breast and Ovarian Cancer 2017 Rebecca Sutphen, MD, FACMG Professor, College of Medicine President & Chief Medical Officer INVASIVE CANCER GENETICALLY ALTERED CELL HYPERPLASIA DYSPLASIA

More information

OUTLINE PAST PRESENTFUTURE BREAST CANCER INCIDENCE AND MORTALITY CURRENT STATE OF MEDICAL ONCOLOGY SECOND ANNUAL BREAST CANCER SYMPOSIUM

OUTLINE PAST PRESENTFUTURE BREAST CANCER INCIDENCE AND MORTALITY CURRENT STATE OF MEDICAL ONCOLOGY SECOND ANNUAL BREAST CANCER SYMPOSIUM OUTLINE CURRENT STATE OF MEDICAL ONCOLOGY SECOND ANNUAL BREAST CANCER SYMPOSIUM October 11, 2014 SARA M GARRIDO, M.D., F.A.C.P Chief Medical Officer at AMS Miami, October 11, 2014 PAST PRESENTFUTURE -BRIEF

More information

Insights and Updates in Breast Cancer. No Disclosures. Learning Objectives. Mountain States Cancer Conference 2017 Regina Jeanise Brown MD

Insights and Updates in Breast Cancer. No Disclosures. Learning Objectives. Mountain States Cancer Conference 2017 Regina Jeanise Brown MD Insights and Updates in Breast Cancer Mountain States Cancer Conference 2017 Regina Jeanise Brown MD 10/14/17 No Disclosures Learning Objectives Understand screening recommendations Understand the effectiveness

More information

This is a summary of what we ll be talking about today.

This is a summary of what we ll be talking about today. Slide 1 Breast Cancer American Cancer Society Reviewed October 2015 Slide 2 What we ll be talking about How common is breast cancer? What is breast cancer? What causes it? What are the risk factors? Can

More information

Breast Cancer. Dr. Andres Wiernik 2017

Breast Cancer. Dr. Andres Wiernik 2017 Breast Cancer Dr. Andres Wiernik 2017 Agenda: The Facts! (Epidemiology/Risk Factors) Biological Classification/Phenotypes of Breast Cancer Treatment approach Local Systemic Agenda: The Facts! (Epidemiology/Risk

More information

Breast Cancer: Current Approaches to Diagnosis and Treatment

Breast Cancer: Current Approaches to Diagnosis and Treatment Breast Cancer: Current Approaches to Diagnosis and Treatment Barbara L. Smith, MD, Ph.D. Massachusetts General Hospital Division of Surgical Oncology No Disclosures Incidence of Breast Cancer USA 2018

More information

Breast Cancer Risk Assessment: Genetics, Risk Models, and Screening. Amie Hass, MSN, ARNP, FNP-BC Hall-Perrine Cancer Center

Breast Cancer Risk Assessment: Genetics, Risk Models, and Screening. Amie Hass, MSN, ARNP, FNP-BC Hall-Perrine Cancer Center Breast Cancer Risk Assessment: Genetics, Risk Models, and Screening Amie Hass, MSN, ARNP, FNP-BC Hall-Perrine Cancer Center Disclosure- I DO NOT HAVE any relevant financial interest with any entity producing,

More information

Susan G. Komen Central and Northern Arizona

Susan G. Komen Central and Northern Arizona Susan G. Komen Central and Northern Arizona Frank Nagy, Mission Director WHY IS EARLY DETECTION IMPORTANT? WHY IS EARLY DETECTION IMPORTANT? Regular screening tests (along with follow-up tests and treatment

More information

Health Disparities Advances in Breast Cancer Treatment. Jo Anne Zujewski April 27, 2009

Health Disparities Advances in Breast Cancer Treatment. Jo Anne Zujewski April 27, 2009 Health Disparities Advances in Breast Cancer Treatment Jo Anne Zujewski April 27, 2009 Disclaimer Breast Cancer Incidence 1994-2003 Breast Cancer Mortality 1994-2003 Access to Care Comorbidity Biology

More information

RVP Medical Director Anthem Blue Cross. Provider Clinical Liaison, Oncology Solutions

RVP Medical Director Anthem Blue Cross. Provider Clinical Liaison, Oncology Solutions David Pryor MD, MPH RVP Medical Director Anthem Blue Cross Leora Fogel Provider Clinical Liaison, Oncology Solutions Remember these key facts: There are things you can do to lower your risk. Progress is

More information

Information leaflet for women with an increased lifetime risk of breast and ovarian cancer. Hereditary Breast and Ovarian Cancer (HBOC)

Information leaflet for women with an increased lifetime risk of breast and ovarian cancer. Hereditary Breast and Ovarian Cancer (HBOC) Information leaflet for women with an increased lifetime risk of breast and ovarian cancer Hereditary Breast and Ovarian Cancer (HBOC) What is Hereditary Breast and Ovarian Cancer (HBOC)? Hereditary Breast

More information

It is a malignancy originating from breast tissue

It is a malignancy originating from breast tissue 59 Breast cancer 1 It is a malignancy originating from breast tissue including both early stages which are potentially curable, and metastatic breast cancer (MBC) which is usually incurable. Most breast

More information

Breast Cancer Risk Assessment and Prevention

Breast Cancer Risk Assessment and Prevention Breast Cancer Risk Assessment and Prevention Katherine B. Lee, MD, FACP October 4, 2017 STATISTICS More than 252,000 cases of breast cancer will be diagnosed this year alone. About 40,000 women will die

More information

Breast Cancer Scanning the Horizon

Breast Cancer Scanning the Horizon Breast Cancer Scanning the Horizon Prof Fran Boyle BCNA Summit Sydney 2013 Feature Interview: Dr Fran Boyle :: Sunday Nights - ABC www.abc.net.au/sundaynights/stories/s1544975.htm Familial breast cancer

More information

Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document.

Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. MRI OF THE BREAST Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs

More information

Updates in Cancer Genetics & Genomics

Updates in Cancer Genetics & Genomics Updates in Cancer Genetics & Genomics Jennifer R. Klemp, PhD, MPH, MA Associate Professor of Medicine, Division of Clinical Oncology Director, Cancer Survivorship Co-Program Leader, Cancer Prevention and

More information

AllinaHealthSystems 1

AllinaHealthSystems 1 Overview Biology and Introduction to the Genetics of Cancer Denise Jones, MS, CGC Certified Genetic Counselor Virginia Piper Cancer Service Line I. Our understanding of cancer the historical perspective

More information

Johns Hopkins Clinical Update Webinar

Johns Hopkins Clinical Update Webinar Johns Hopkins Clinical Update Webinar Ben Ho Park, M.D., Ph.D. Department of Oncology Johns Hopkins University February 2015 This presentation is the intellectual property of the author/presenter. Contact

More information

Diseases of the breast (2 of 2) Breast cancer

Diseases of the breast (2 of 2) Breast cancer Diseases of the breast (2 of 2) Breast cancer Epidemiology & etiology The most common type of cancer & the 2 nd most common cause of cancer death in women 1 of 8 women in USA Affects 7% of women Peak at

More information

Overview of peculiarities and therapeutic options for patients with breast cancer and a BRCA germline mutation

Overview of peculiarities and therapeutic options for patients with breast cancer and a BRCA germline mutation Overview of peculiarities and therapeutic options for patients with breast cancer and a BRCA germline mutation Dr Niklas Loman PhD MD Consultant oncologist Skåne University Hospital Lund, Suecia Prognosis

More information

Mammography and Other Screening Tests. for Breast Problems

Mammography and Other Screening Tests. for Breast Problems 301.681.3400 OBGYNCWC.COM Mammography and Other Screening Tests What is a screening test? for Breast Problems A screening test is used to find diseases, such as cancer, in people who do not have signs

More information

So how much of breast and ovarian cancer is hereditary? A). 5 to 10 percent. B). 20 to 30 percent. C). 50 percent. Or D). 65 to 70 percent.

So how much of breast and ovarian cancer is hereditary? A). 5 to 10 percent. B). 20 to 30 percent. C). 50 percent. Or D). 65 to 70 percent. Welcome. My name is Amanda Brandt. I am one of the Cancer Genetic Counselors at the University of Texas MD Anderson Cancer Center. Today, we are going to be discussing how to identify patients at high

More information

Clinical Trials In A New Age:

Clinical Trials In A New Age: Sharsheret 2015 SHARSHERET Clinical Trials In A New Age: How You Can Connect Wednesday, February 25, 2015 To listen to the presentation by phone, Dial: 866-952-1906 Code: TRIALS Sharsheret 2015 WELCOME

More information

Key Recommendations. Gynecologic management of women with inherited risk of gynecologic cancer

Key Recommendations. Gynecologic management of women with inherited risk of gynecologic cancer Gynecologic management of women with inherited risk of gynecologic cancer C. Bethan Powell MD Kaiser Permanente Northern California Gynecologic Oncology Program Lead, Kaiser Permanente Northern California

More information

Metastatic Breast Cancer What is new? Subtypes and variation?

Metastatic Breast Cancer What is new? Subtypes and variation? Metastatic Breast Cancer What is new? Subtypes and variation? Anne Blaes, MD, MS University of Minnesota, Division of Hematology/Oncology Director, Adult Cancer Survivor Program Current estimates for metastatic

More information

One Breast Cancer Annual Report

One Breast Cancer Annual Report One 2015 Breast Cancer Annual Report One OVERVIEW The Breast Program at Carolinas HealthCare System s Levine Cancer Institute, offers comprehensive care. Patients with benign and malignant disease of the

More information

GeneHealth BRCA 1&2_ qxp_Layout 1 21/02/ :44 Page 3 BRCA1 & BRCA2 GeneHealth UK

GeneHealth BRCA 1&2_ qxp_Layout 1 21/02/ :44 Page 3 BRCA1 & BRCA2 GeneHealth UK GeneHealth BRCA 1&2_8.2.17.qxp_Layout 1 21/02/2017 16:44 Page 3 BRCA1 & BRCA2 GeneHealth UK GeneHealth BRCA 1&2_8.2.17.qxp_Layout 1 21/02/2017 16:44 Page 4 BRCA1 & BRCA2 What is hereditary breast cancer?

More information

BRCAnowTM It s Your Decision

BRCAnowTM It s Your Decision Hereditary Breast and Ovarian Cancer BRCAnowTM It s Your Decision Patient & Physician Information What is BRCA? The breast cancer genes BRCA1 and BRCA2 are found within an individual s normal genetic makeup;

More information

Passport to Health Preventing and Recognizing Gynecologic Cancers

Passport to Health Preventing and Recognizing Gynecologic Cancers Passport to Health Preventing and Recognizing Gynecologic Cancers Presented by: Obstetrician/Gynecologist Leigh Bauer, M.D. They can sneak up on you. 2 Gynecologic cancers, that is. Knowing the facts can

More information

The impact of hereditary breast and ovarian cancer (HBOC) syndrome testing on patient management and your practice

The impact of hereditary breast and ovarian cancer (HBOC) syndrome testing on patient management and your practice The impact of hereditary breast and ovarian cancer (HBOC) syndrome testing on patient management and your practice Use BRACAnalysis as a guide in your medical and surgical management BRACAnalysis testing

More information

UK Interdisciplinary Breast Cancer Symposium. Should lobular phenotype be considered when deciding treatment? Michael J Kerin

UK Interdisciplinary Breast Cancer Symposium. Should lobular phenotype be considered when deciding treatment? Michael J Kerin UK Interdisciplinary Breast Cancer Symposium Should lobular phenotype be considered when deciding treatment? Michael J Kerin Professor of Surgery National University of Ireland, Galway and Galway University

More information

Utilization of BRCA Testing. Breast and Ovarian Cancer in Texas

Utilization of BRCA Testing. Breast and Ovarian Cancer in Texas Utilization of BRCA Testing in Older Ode Women with Breast and Ovarian Cancer in Texas Ana M. Rodriguez, MD Assistant Professor Department of Obstetrics and Gynecology University of Texas Medical Branch

More information

Management of BRCA Positive Breast Cancer. Archana Ganaraj, MD February 17, 2018 UPDATE ON WOMEN S HEALTH

Management of BRCA Positive Breast Cancer. Archana Ganaraj, MD February 17, 2018 UPDATE ON WOMEN S HEALTH Management of BRCA Positive Breast Cancer Archana Ganaraj, MD February 17, 2018 UPDATE ON WOMEN S HEALTH The number of American women who have lost their lives to breast cancer outstrips the total number

More information

10/15/2012. Inflammatory Breast Cancer vs. LABC: Different Biology yet Subtypes Exist

10/15/2012. Inflammatory Breast Cancer vs. LABC: Different Biology yet Subtypes Exist Triple-Negative Breast Cancer: Optimizing Treatment for Locally Advanced Breast Cancer Beth Overmoyer MD Director, Inflammatory Breast Cancer Program Dana Farber Cancer Institute Overview Inflammatory

More information

The Genetics of Breast and Ovarian Cancer Prof. Piri L. Welcsh

The Genetics of Breast and Ovarian Cancer Prof. Piri L. Welcsh The Genetics of Breast Piri L. Welcsh, PhD Research Assistant Professor University of Washington School of Medicine Division of Medical Genetics 1 Genetics of cancer All cancers arise from genetic and

More information

SYSTEMIC TREATMENT OF TRIPLE NEGATIVE BREAST CANCER

SYSTEMIC TREATMENT OF TRIPLE NEGATIVE BREAST CANCER SYSTEMIC TREATMENT OF TRIPLE NEGATIVE BREAST CANCER Sunil Shrestha 1*, Ji Yuan Yang, Li Shuang and Deepika Dhakal Clinical School of Medicine, Yangtze University, Jingzhou, Hubei Province, PR. China Department

More information

Adjuvant Systemic Therapy in Early Stage Breast Cancer

Adjuvant Systemic Therapy in Early Stage Breast Cancer Adjuvant Systemic Therapy in Early Stage Breast Cancer Julie R. Gralow, M.D. Director, Breast Medical Oncology Jill Bennett Endowed Professor of Breast Cancer Professor, Global Health University of Washington

More information

How often should I get a mammogram?

How often should I get a mammogram? How often should I get a mammogram? Ages 50-74 BREAST CANCER SCREENING This photo is for illustrative purposes only, and the person depicted in the photograph is a model. An affiliation between Central

More information

CLINICAL GUIDELINES. Screening Mammography Guidelines

CLINICAL GUIDELINES. Screening Mammography Guidelines CLINICAL GUIDELINES Screening Mammography Guidelines Paula George, M.D. and C. Todd Cunningham, M.D., Karen F. Goodhope, M.D., Valerie C. Reichert, M.D. Hayley Sheldon, M.D., Michelle Walters, D.O. 2/17/2016

More information